More heart failure patients will be taking an aldosterone antagonist

November 2003

More heart failure patients will be taking an aldosterone antagonist...spironolactone or the new Inspra (eplerenone).

These drugs have been shown to improve survival...but in different types of patients.

Spironolactone improves survival in patients with Class III or IV heart failure and reduced left ventricular function.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: PA includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

More heart failure patients will be taking an aldosterone antagonist
Zomig NASAL SPRAY
possible link between atypical antipsychotics and diabetes
Men's Health Levitra (vardenafil) will work in some men who don't respond to Viagra
Alzheimer's Disease new Alzheimer's drug, memantine (Namenda)
Cardiology who should take aspirin for primary prevention of heart disease...and how much they should take
Cardiology new warnings about a potential interaction between cranberry juice and warfarin
Infectious Diseases new injectable antibiotic called Cubicin
Infectious Diseases Does the chickenpox vaccine (Varivax) prevent shingles
Infectious Diseases Two commonly-used antibiotics will come in dispersible tablets
Neurology & Pain confusion between the new Darvocet A500 and Darvocet-N 100
Hematology & Oncology Femara (letrozole) for early-stage breast cancer
new protease inhibitor called Lexiva
Osteoporosis thiazide diuretics reduce the risk of fractures from osteoporosis
Osteoporosis combo treatment for osteoporosis
Medication Errors Look- and sound-alike drug names are creating mistakes